Vor Biopharma Inc (VOR)
1.765
0.00 (0.00%)
USD |
NASDAQ |
May 07, 16:00
1.765
0.00 (0.00%)
After-Hours: 20:00
Vor Biopharma Enterprise Value: -17.20M for May 6, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 06, 2024 | -17.20M |
| May 03, 2024 | -14.47M |
| May 02, 2024 | -17.20M |
| May 01, 2024 | -16.52M |
| April 30, 2024 | -19.92M |
| April 29, 2024 | -18.56M |
| April 26, 2024 | -21.97M |
| April 25, 2024 | -21.29M |
| April 24, 2024 | -18.56M |
| April 23, 2024 | -9.018M |
| April 22, 2024 | -13.11M |
| April 19, 2024 | -20.61M |
| April 18, 2024 | -22.65M |
| April 17, 2024 | -19.24M |
| April 16, 2024 | -20.61M |
| April 15, 2024 | -14.47M |
| April 12, 2024 | -7.654M |
| April 11, 2024 | 1.889M |
| April 10, 2024 | -2.882M |
| April 09, 2024 | 5.298M |
| April 08, 2024 | 12.11M |
| April 05, 2024 | 10.07M |
| April 04, 2024 | 4.616M |
| April 03, 2024 | 5.980M |
| April 02, 2024 | 5.298M |
| Date | Value |
|---|---|
| April 01, 2024 | 12.80M |
| March 28, 2024 | 24.39M |
| March 27, 2024 | 13.48M |
| March 26, 2024 | 10.07M |
| March 25, 2024 | 1.889M |
| March 22, 2024 | -5.609M |
| March 21, 2024 | -3.564M |
| March 20, 2024 | -14.47M |
| March 19, 2024 | -13.11M |
| March 18, 2024 | -6.291M |
| March 15, 2024 | -5.609M |
| March 14, 2024 | -11.92M |
| March 13, 2024 | -0.7135M |
| March 12, 2024 | -0.7135M |
| March 11, 2024 | 5.397M |
| March 08, 2024 | 21.69M |
| March 07, 2024 | 12.86M |
| March 06, 2024 | 8.112M |
| March 05, 2024 | 11.51M |
| March 04, 2024 | 18.98M |
| March 01, 2024 | 16.94M |
| February 29, 2024 | 18.98M |
| February 28, 2024 | 9.470M |
| February 27, 2024 | -2.071M |
| February 26, 2024 | -2.411M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-47.91M
Minimum
Nov 01 2023
2.066B
Maximum
Feb 25 2021
209.56M
Average
77.04M
Median
May 11 2023
Enterprise Value Benchmarks
| Masimo Corp | 8.044B |
| AnaptysBio Inc | 298.78M |
| Apellis Pharmaceuticals Inc | 5.633B |
| NovaBay Pharmaceuticals Inc | 2.696M |
| Palatin Technologies Inc | 22.79M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -26.26M |
| Total Expenses (Quarterly) | 28.12M |
| EPS Diluted (Quarterly) | -0.38 |
| Earnings Yield | -99.15% |